Factors that influence infliximab biosimilar trough levels in the pediatric inflammatory bowel disease population

CONCLUSIONS: This study discovered some predictors for IFX-BioS TLs in IBD children. Knowledge of predictive factors could help physicians choose the best dosing regimen.PMID:37962991 | DOI:10.1080/1744666X.2023.2284226

Source: Expert Review of Clinical Immunology - November 14, 2023 Category: Allergy & Immunology Authors: Valeria Dipasquale Angela Alibrandi Salvatore Pellegrino Vincenzo Ramistella Claudio Romano Source Type: research